Angiotensin receptor blockers following acute stroke

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 6, 2011, Pages 691-696

  Rhoney, Denise H ^a   Moser, Lynette R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

acute stroke; ARB; blood pressure; intracerebral hemorrhage; ischemic stroke; outcome

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STROKE; TREATMENT OUTCOME;

EID: 79959877853     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.60     Document Type: Article

References (42)

1. Bath P, Chalmers J, Powers W et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J. Hypertens. 21, 665-672 (2003)
2. Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown RD Jr. Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology 65, 1179-1183 (2005) (Pubitemid 41508207)
3. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33, 1315-1320 (2002) (Pubitemid 34517053)
4. Castillo J, Leira R, Garcia MM et al. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 35, 520-526 (2004)
5. Adams HP Jr, del Zoppo G, Alberts MJ et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38, 1655-1711 (2007) (Pubitemid 46691097)
6. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 17, 861-864 (1986) (Pubitemid 16000718)
7. Oliveira-Filho J, Silva SC, Trabuco CC et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 61, 1047-1051 (2003) (Pubitemid 37461935)
8. Mattle HP, Kappeler L, Arnold M et al. Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 36, 264-268 (2005) (Pubitemid 40170805)
9. Ohwaki K, Yano E, Nagashima H et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35, 1364-1367 (2004) (Pubitemid 38697459)
10. Powers WJ. Intracerebral hemorrhage and head trauma: common effects and common mechanisms of injury. Stroke 41, S107-S110 (2010)
11. Anderson CS, Huang Y, Wang JG et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 7, 391-399 (2008)
12. Qureshi AI, Palesch YY, Martin R et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch. Neurol. 67, 570-576 (2010)
13. Arima H, Anderson CS, Wang JG et al. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension 56, 852-858 (2010)
14. Saad MA, Abbas AM, Boshra V, Elkhateeb M, El Aal IA. Effect of angiotensin II type 1 receptor blocker, candesartan, and b 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Acta Physiol. Hung. 97, 159-171 (2010)
15. Jilma B, Li-Saw-Hee FL, Wagner OF, Beevers DG , Lip GY. Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. Clin. Sci. (Lond.) 103, 131-136 (2002)
16. Li J, Culman J, Hortnagl H et al. Angiotensin AT2 receptor protects against cerebral ischemia-induced neuronal injury. FASEB J. 19, 617-619 (2005) (Pubitemid 40471263)
17. Iwai M, Liu HW, Chen R et al. Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation. Circulation 110, 843-848 (2004) (Pubitemid 39096013)
18. Krikov M, Thone-Reineke C, Muller S, Villringer A, Unger T. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. J. Hypertens. 26, 544-552 (2008) (Pubitemid 351317265)
19. Kozak W, Kozak A, Johnson MH, Elewa HF, Fagan SC. Vascular protection with candesartan after experimental acute stroke in hypertensive rats: a dose-response study. J. Pharmacol. Exp. Ther. 326, 773-782 (2008)
20. Kozak A, Ergul A, El-Remessy AB et al. Candesartan augments ischemia-induced proangiogenic state and results in sustained improvement after stroke. Stroke 40, 1870-1876 (2009).
21. Fagan SC, Hess DC, Machado LS et al. Tactics for vascular protection after acute ischemic stroke. Pharmacotherapy 25, 387-395 (2005) (Pubitemid 40300326)
22. Fagan SC, Kozak A, Hill WD et al. Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection. J. Hypertens. 24, 535-539 (2006) (Pubitemid 43261918)
23. Schrader J, Luders S, Kulschewski A et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34, 1699-1703 (2003) (Pubitemid 36842630)
24. Rodriguez-Garcia JL, Botia E, de La Sierra A, Villanueva MA, Gonzalez-Spinola J. Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke. Am. J. Hypertens. 18, 379-384 (2005) (Pubitemid 40409920)
25. Potter JF, Robinson TG, Ford GA et al. Controlling Hypertension and Hypotension Immediately Post-Stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 8, 48-56 (2009)
26. Nakamura T, Tsutsumi Y, Shimizu Y, Uchiyama S. Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase. J. Stroke Cerebrovasc. Dis. 19, 435-440 (2010)
27. Bath PM, Martin RH, Palesch Y et al. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke 40, 3541-3546 (2009)
28. Morgenstern LB, Hemphill JC 3rd, Anderson C et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41, 2108-2129 (2010)
29. Sandset EC, Bath PM, Boysen G et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 377, 741-750 (2011)
30. Sare, GM, Ali M, Shuaib A, Bath PM. Relationship between hyperacute blood pressure and outcome after ischemic stroke: data from the VISTA collaboration. Stroke 40, 2098-2103 (2009)
31. Brott T, Broderick J, Kothari R et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28, 1-5 (1997) (Pubitemid 27039454)
32. Ovbiagele, B, Saver JL, Fredieu A et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke 35, 2879-2883 (2004) (Pubitemid 39565188)
33. Geeganage C, Tracy M, England T et al. Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)Stroke 42, 491-493 (2011)
34. Yong M, Diener HC, Kaste M, Mau J. Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 36, 2619-2625 (2005)
35. Ko Y, Park JH, Yang MH et al. The significance of blood pressure variability for the development of hemorrhagic transformation in acute ischemic stroke. Stroke 41, 2512-2518 (2010)
36. Rothwell PM, Howard SC, Dolan E et al. Effects of b blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol. 9, 469-480 (2010)
37. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensiv-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 375, 906-915 (2010)
38. Leira R, Millan M, Diez-Tejedor E et al. Age determines the effects of blood pressure lowering during the acute phase of ischemic stroke: the TICA study. Hypertension 54, 769-774 (2009)
39. Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br. Med. J. 1, 507-510 (1973)
40. Spence JD. Pseudo-hypertension in the elderly: still hazy, after all these years. J. Hum. Hypertens. 11, 621-623 (1997) (Pubitemid 27494055)
41. Robinson TG, Potter JF, Ford GA et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 9, 767-775 (2010)
42. Anderson, CS, Huang Y, Arima H et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT)Stroke 41, 307-312 (2010).